Evaluating the safety and efficacy of biologics in psoriatic patients with malignancies: Insights and future directions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating the safety and efficacy of biologics in psoriatic patients with malignancies: Insights and future directions

Published:2024-06-24 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Yu Sebastian¹²³^ORCID,Wei James Cheng‐Chung⁴⁵⁶^ORCID

Affiliation:

1. Department of Dermatology, School of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung Taiwan

2. Department of Dermatology Kaohsiung Medical University Gangshan Hospital Kaohsiung Taiwan

3. Master of Public Health Degree Program, College of Public Health National Taiwan University Taipei Taiwan

4. Institute of Medicine Chung Shan Medical University Taichung Taiwan

5. Department of Allergy, Immunology & Rheumatology Chung Shan Medical University Hospital Taichung Taiwan

6. Graduate Institute of Integrated Medicine China Medical University Taichung Taiwan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20195

Reference10 articles.

1. Biologics in psoriatic patients with malignancies: Where are we now? An Italian multicentric study

2. Risk of malignancy in patients with psoriasis according to treatment modalities in Korea: a nationwide cohort study

3. EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

4. Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis

5. Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comments on ‘Evaluating the safety and efficacy of biologics in psoriatic patients with malignancies: Insights and future directions’;Journal of the European Academy of Dermatology and Venereology;2024-07-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3